MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,003,912 | +7.0% | 500,367 | +33.0% | 0.00% | 0.0% |
| Q2 2023 | $4,677,316 | +16.9% | 376,312 | +31.8% | 0.00% | 0.0% |
| Q1 2023 | $4,000,186 | +60.3% | 285,541 | +63.7% | 0.00% | +50.0% |
| Q4 2022 | $2,495,747 | -47.9% | 174,421 | -53.4% | 0.00% | -50.0% |
| Q3 2022 | $4,787,783 | -0.9% | 374,674 | +120.4% | 0.00% | +33.3% |
| Q2 2022 | $4,829,000 | -11.5% | 170,001 | +9.8% | 0.00% | 0.0% |
| Q1 2022 | $5,458,000 | -34.1% | 154,765 | -21.7% | 0.00% | 0.0% |
| Q4 2021 | $8,287,000 | -51.4% | 197,762 | -43.0% | 0.00% | -57.1% |
| Q3 2021 | $17,047,000 | +121.4% | 347,243 | +88.2% | 0.01% | +133.3% |
| Q2 2021 | $7,701,000 | -66.5% | 184,532 | -77.5% | 0.00% | -72.7% |
| Q4 2020 | $23,009,000 | – | 820,275 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |